Advertisement

Acute Hepatitis

  • Yoshinori HaradaEmail author
  • Masaki Iwai
Chapter

Abstract

Acute viral hepatitis is sporadic or endemic mainly due to hepatitis virus. It is spread by the oral-fecal route or parenterally by blood transfusion, intravenous drug abuse, and sexual intercourse. The hepatitis virus is defined as a virus that has a greater affinity for the liver and produces a characteristic inflammatory reaction in the liver. The virus includes types A, B, C, D, and E. Types A is transmitted via the oral-fecal route, whereas types B, C, and D are transmitted by parenteral route. Type E is mostly transmitted through the fecal-oral route, but it can be transmitted via blood transfusions (Table 3.1). Systemic infections of Epstein-Barr virus (EBV), cytomegalovirus, herpesvirus, adenovirus, and rubella rarely produce acute concomitant hepatitis. EBV causes hepatitis in the acute phase of systemic infection; and acute hepatitis due to herpesvirus, cytomegalovirus, adenovirus, or rubella occurs in immunosuppressed patients and young children.

Keywords

Hepatitis virus Fecal-oral route Parenteral route Jaundice Serological indicator 

Abbreviations

CMV

Cytomegalovirus

DIC

Disseminated intravascular coagulation

EBNA

EBV nuclear antigen

EBV

Epstein-Barr virus

HAV

Hepatitis A virus

HBV

Hepatitis B virus

HCV

Hepatitis C virus

HDV

Hepatitis D virus

HEV

Hepatitis E virus

HSV

Herpes simplex virus

IgM-HA

Anti-HAV IgM antibody

VCA

Viral-capsid antigen

Notes

Acknowledgments

Prof. Paul Y. Kwo was a coauthor of the first edition of this chapter.

References

  1. 1.
    Martin A, Lemon SM. Hepatitis A virus: from discovery to vaccines. Hepatology. 2006;43(S1):S164–72.CrossRefGoogle Scholar
  2. 2.
    Kumar V, Abbas AK, Aster JC. Robbins basic pathology E-book. New York: Elsevier Health Sciences; 2017.Google Scholar
  3. 3.
    Feinstone SM, Kapikian AZ, Purceli RH. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science. 1973;182(4116):1026–8.CrossRefGoogle Scholar
  4. 4.
    Abe H, et al. Light microscopic findings of liver biopsy specimens from patients with hepatitis type A and comparison with type B. Gastroenterology. 1982;82(5 Pt 1):938–47.PubMedGoogle Scholar
  5. 5.
    Teixeira MR, et al. The pathology of hepatitis A in man. Liver. 1982;2(1):53–60.CrossRefGoogle Scholar
  6. 6.
    Watanabe M, et al. Hepatitis A virus infection associated with hemophagocytic syndrome: report of two cases. Intern Med. 2002;41(12):1188–92.CrossRefGoogle Scholar
  7. 7.
    Yuen MF, Lai CL. Hepatitis B virus genotypes: natural history and implications for treatment. Expert Rev Gastroenterol Hepatol. 2007;1(2):321–8.CrossRefGoogle Scholar
  8. 8.
    Kramvis A, Kew M, Francois G. Hepatitis B virus genotypes. Vaccine. 2005;23(19):2409–23.CrossRefGoogle Scholar
  9. 9.
    Yu H, et al. Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype “I”. PLoS One. 2010;5(2):e9297.CrossRefGoogle Scholar
  10. 10.
    Tatematsu K, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol. 2009;83(20):10538–47.CrossRefGoogle Scholar
  11. 11.
    Jake LT. Hepatitis B: the virus and disease. Hepatology. 2009;49(S5):S13–21.CrossRefGoogle Scholar
  12. 12.
    Atsushi O, et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology. 2006;44(2):326–34.CrossRefGoogle Scholar
  13. 13.
    De Francesco R. Molecular virology of the hepatitis C virus. J Hepatol. 1999;31:47–53.CrossRefGoogle Scholar
  14. 14.
    Orland JR, Wright TL, Cooper S. Acute hepatitis C. Hepatology. 2001;33(2):321–7.CrossRefGoogle Scholar
  15. 15.
    Blackard JT, et al. Acute hepatitis C virus infection: a chronic problem. Hepatology (Baltimore, MD). 2008;47(1):321–31.CrossRefGoogle Scholar
  16. 16.
    Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C. Lancet. 2008;372(9635):321–32.CrossRefGoogle Scholar
  17. 17.
    Santantonio T, Wiegand J, Tilman Gerlach J. Acute hepatitis C: current status and remaining challenges. J Hepatol. 2008;49(4):625–33.CrossRefGoogle Scholar
  18. 18.
    Mondelli MU, Cerino A, Cividini A. Acute hepatitis C: diagnosis and management. J Hepatol. 2005;42(Suppl 1):S108–14.CrossRefGoogle Scholar
  19. 19.
    Jean-Michel P. Use and interpretation of virological tests for hepatitis C. Hepatology. 2002;36(5B):s65–73.CrossRefGoogle Scholar
  20. 20.
    Bamber M, et al. Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut. 1981;22(10):854–9.CrossRefGoogle Scholar
  21. 21.
    Kamar N, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358(8):811–7.CrossRefGoogle Scholar
  22. 22.
    Smith DB, et al. Consensus proposals for classification of the family Hepeviridae. J Gen Virol. 2014;95(Pt 10):2223–32.CrossRefGoogle Scholar
  23. 23.
    Tei S, et al. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet. 2003;362(9381):371–3.CrossRefGoogle Scholar
  24. 24.
    Rakesh A, Krzysztof K. Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol. 2000;15(1):9–20.CrossRefGoogle Scholar
  25. 25.
    Nanda SK, et al. Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol. 1994;42(2):133–7.CrossRefGoogle Scholar
  26. 26.
    Dienes HP, et al. Hepatitis A-like non-A, non-B hepatitis: light and electron microscopic observations of three cases. Virchows Arch A Pathol Anat Histopathol. 1986;409(5):657–67.CrossRefGoogle Scholar
  27. 27.
    Takahashi M, et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J Clin Microbiol. 2005;43(1):49–56.CrossRefGoogle Scholar
  28. 28.
    Davern TJ, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology. 2011;141(5):1665–72.e1-9.CrossRefGoogle Scholar
  29. 29.
    Ankcorn MJ, Tedder RS. Hepatitis E: the current state of play. Transfus Med. 2017;27(2):84–95.CrossRefGoogle Scholar
  30. 30.
    Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010;362(21):1993–2000.CrossRefGoogle Scholar
  31. 31.
    Hinedi TB, Koff RS. Cholestatic hepatitis induced by Epstein-Barr virus infection in an adult. Dig Dis Sci. 2003;48(3):539–41.CrossRefGoogle Scholar
  32. 32.
    Edoute Y, et al. Severe cholestatic jaundice induced by Epstein-Barr virus infection in the elderly. J Gastroenterol Hepatol. 1998;13(8):821–4.CrossRefGoogle Scholar
  33. 33.
    Papatheodoridis GV, et al. Fulminant hepatitis due to Epstein-Barr virus infection. J Hepatol. 1995;23(3):348–50.CrossRefGoogle Scholar
  34. 34.
    Purtilo DT, Sakamoto K. Epstein-Barr virus and human disease: immune responses determine the clinical and pathologic expression. Hum Pathol. 1981;12(8):677–9.CrossRefGoogle Scholar
  35. 35.
    Ohshima K, et al. Clinicopathological findings of virus-associated hemophagocytic syndrome in bone marrow: association with Epstein-Barr virus and apoptosis. Pathol Int. 1999;49(6):533–40.CrossRefGoogle Scholar
  36. 36.
    Marcelin JR, Beam E, Razonable RR. Cytomegalovirus infection in liver transplant recipients: updates on clinical management. World J Gastroenterol. 2014;20(31):10658–67.CrossRefGoogle Scholar
  37. 37.
    Fowler KB, Boppana SB. Congenital cytomegalovirus infection. Semin Perinatol. 2018;42(3):149–54.CrossRefGoogle Scholar
  38. 38.
    Cohen JI, Corey GR. Cytomegalovirus infection in the normal host. Medicine (Baltimore). 1985;64(2):100–14.CrossRefGoogle Scholar
  39. 39.
    Evans AS. Infectious mononucleosis and related syndromes. Am J Med Sci. 1978;276(3):325–39.CrossRefGoogle Scholar
  40. 40.
    Rowshani AT, et al. Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. Transplantation. 2005;79(4):381–6.CrossRefGoogle Scholar
  41. 41.
    Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev. 2002;15(4):680–715.CrossRefGoogle Scholar
  42. 42.
    Demetris AJ, et al. Pathology of hepatic transplantation: a review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol. 1985;118(1):151–61.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Colina F, et al. Histological diagnosis of cytomegalovirus hepatitis in liver allografts. J Clin Pathol. 1995;48(4):351–7.CrossRefGoogle Scholar
  44. 44.
    Kaufman B, et al. Herpes simplex virus hepatitis: case report and review. Clin Infect Dis. 1997;24(3):334–8.CrossRefGoogle Scholar
  45. 45.
    Norvell JP, et al. Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases. Liver Transpl. 2007;13(10):1428–34.CrossRefGoogle Scholar
  46. 46.
    Natu A, Iuppa G, Packer CD. Herpes simplex virus hepatitis: a presentation of multi-institutional cases to promote early diagnosis and management of the disease. Case Rep Hepatol. 2017;2017:3180984.Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.KyotoJapan
  2. 2.KyotoJapan

Personalised recommendations